Aspire Biopharma Stock Market Value
| ASBP Stock | 1.39 0.06 4.14% |
| Symbol | Aspire |
Can Pharmaceuticals industry sustain growth momentum? Does Aspire have expansion opportunities? Factors like these will boost the valuation of Aspire BioPharma. If investors know Aspire will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Aspire BioPharma demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Aspire BioPharma's market price often diverges from its book value, the accounting figure shown on Aspire's balance sheet. Smart investors calculate Aspire BioPharma's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Aspire BioPharma's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Aspire BioPharma's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aspire BioPharma represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Aspire BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Aspire BioPharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aspire BioPharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aspire BioPharma.
| 12/02/2025 |
| 03/02/2026 |
If you would invest 0.00 in Aspire BioPharma on December 2, 2025 and sell it all today you would earn a total of 0.00 from holding Aspire BioPharma or generate 0.0% return on investment in Aspire BioPharma over 90 days. Aspire BioPharma is related to or competes with AleAnna. Aspire BioPharma is entity of United States More
Aspire BioPharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aspire BioPharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aspire BioPharma upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.1) | |||
| Maximum Drawdown | 66.08 | |||
| Value At Risk | (16.05) | |||
| Potential Upside | 19.52 |
Aspire BioPharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aspire BioPharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aspire BioPharma's standard deviation. In reality, there are many statistical measures that can use Aspire BioPharma historical prices to predict the future Aspire BioPharma's volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (1.06) | |||
| Total Risk Alpha | (2.15) | |||
| Treynor Ratio | (1.03) |
Aspire BioPharma March 2, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (1.02) | |||
| Mean Deviation | 7.51 | |||
| Coefficient Of Variation | (1,144) | |||
| Standard Deviation | 11.16 | |||
| Variance | 124.5 | |||
| Information Ratio | (0.1) | |||
| Jensen Alpha | (1.06) | |||
| Total Risk Alpha | (2.15) | |||
| Treynor Ratio | (1.03) | |||
| Maximum Drawdown | 66.08 | |||
| Value At Risk | (16.05) | |||
| Potential Upside | 19.52 | |||
| Skewness | 1.44 | |||
| Kurtosis | 4.85 |
Aspire BioPharma Backtested Returns
Aspire BioPharma secures Sharpe Ratio (or Efficiency) of -0.0953, which signifies that the company had a -0.0953 % return per unit of risk over the last 3 months. Aspire BioPharma exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Aspire BioPharma's Standard Deviation of 11.16, risk adjusted performance of (0.06), and Mean Deviation of 7.51 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Aspire BioPharma returns are very sensitive to returns on the market. As the market goes up or down, Aspire BioPharma is expected to follow. At this point, Aspire BioPharma has a negative expected return of -1.1%. Please make sure to confirm Aspire BioPharma's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if Aspire BioPharma performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.14 |
Insignificant reverse predictability
Aspire BioPharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between Aspire BioPharma time series from 2nd of December 2025 to 16th of January 2026 and 16th of January 2026 to 2nd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aspire BioPharma price movement. The serial correlation of -0.14 indicates that less than 14.0% of current Aspire BioPharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.14 | |
| Spearman Rank Test | -0.3 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Pair Trading with Aspire BioPharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aspire BioPharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aspire BioPharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Aspire Stock
Moving against Aspire Stock
| 0.93 | DYF1 | Dynavax Technologies | PairCorr |
| 0.86 | 761 | PHARMANUTRA SPA | PairCorr |
| 0.83 | PFE | Pfizer Inc CDR | PairCorr |
| 0.82 | RHO6 | Roche Holding | PairCorr |
| 0.81 | RO | Roche Holding AG | PairCorr |
The ability to find closely correlated positions to Aspire BioPharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aspire BioPharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aspire BioPharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aspire BioPharma to buy it.
The correlation of Aspire BioPharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aspire BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aspire BioPharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aspire BioPharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Aspire Stock Analysis
When running Aspire BioPharma's price analysis, check to measure Aspire BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aspire BioPharma is operating at the current time. Most of Aspire BioPharma's value examination focuses on studying past and present price action to predict the probability of Aspire BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aspire BioPharma's price. Additionally, you may evaluate how the addition of Aspire BioPharma to your portfolios can decrease your overall portfolio volatility.